James Evans has Medical Oncology as his primary medical specialty. Their primary office is: 809 University Blvd E in Tuscaloosa, Alabama.
They're a part of the: Dch Healthcare Authority medical group which has around 14 members. You can call their office at 205-759-7800 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Alabama School Of Medicine and graduated in 2008 (around 17 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
James Evans
Dch Healthcare Authority
809 University Blvd E
Tuscaloosa, Alabama 35401
205-759-7800
Phone: 205-759-7800
Enter a starting address:
Additional Medical Specialties Include:
HEMATOLOGY
Medical School: University Of Alabama School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for James Evans is listed as: Medical Oncology
Approximate Years of Experience: 17
PAC (PECOS ID)#: 0749453454
NPI #: 1134384787
NPI Created On: 07/23/2008
NPI Last Updated Listed as: 10/18/2016
Primary Taxonomy Code: 207RH0003X
License Number:
33826
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787910586
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787910593
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787910599
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787910605
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 799850207
Being Disputed:: No
Product Related: Yes
Drug or Biological: Device
Product Category #1: ONCOLOGY
Name of Drug #1: FOUNDATIONONE
Drug or Biological: Device
Product Category #2: ONCOLOGY
Name Of Drug #2:: FOUNDATIONONE HEME
Drug or Biological #3:: Device
Product Category #3: ONCOLOGY
Name of Drug: FOUNDATIONONE CDX
Drug or Biological: Device
Product Category #4: ONCOLOGY
Name of Drug #4: FOUNDATIONFOCUS
Drug or Biological #4:: Device
Product Category #5: ONCOLOGY
Name of Drug #5: FOUNDATIONONE LIQUID CDX
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781010205
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781010207
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781010209
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781010211
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 801978479
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: ONCOLOGY
Name of Drug #1: BLENREP
Open Associated Drug #1: 0173-0896-01
809 University Blvd E
Tuscaloosa, AL
Dch Healthcare Authority
809 University Blvd E
Tuscaloosa Al 35401-2029
Dch Healthcare Authority
Nurse Practitioner
1653 Temple Ave N
Fayette Al 35555-1314
Dch Healthcare Authority
Nurse Practitioner
809 University Blvd E
Tuscaloosa Al 35401-2029
Dch Healthcare Authority
Hematology/oncology
1653 Temple Ave N
Fayette Al 35555-1314
Dch Healthcare Authority
Hematology/oncology
809 University Blvd E
Tuscaloosa Al 35401-2029
Dch Healthcare Authority
Internal Medicine
809 University Blvd E
Tuscaloosa Al 35401-2029
Dch Healthcare Authority
Radiation Oncology
View all 14 members of Dch Healthcare Authority medical group